One viral TikTok, 10 million+ views, and a flood of fearless, funny, and unfiltered replies later, a non-hormonal birth ...

Windtree Therapeutics said it has contracted with a pharmaceutical manufacturer in China to produce Evofem Biosciences's hormone-free contraceptive product Phexxi at a low cost.

Evofem's commercial team relaunched SOLOSEC in November 2024 and promotes the product alongside PHEXXI to OB/GYNs in the U.S. 2024 marked Evofem's fourth consecutive year of net sales growth.

Women's health innovator Evofem Biosciences, Inc. (OTCPK: EVFM) announced today that private Emirati health care company Pharma 1 Drug Store LLC has filed an application with the United Arab ...

Evofem is entering global markets through strategic partnerships, including its license agreements with Pharma 1 Drug Store LLC under which PHEXXI and SOLOSEC are expected to launch in the United ...

Women's health innovator Evofem Biosciences, Inc. (OTCPK: EVFM) announced today that private Emirati health care company Pharma 1 Drug Store LLC has filed an application with the United Arab Emirates ...

As part of its 2026 monetization strategy, Aditxt is positioning Pearsanta for an initial public offering. The plan reflects Aditxt's broader vision to build a global, socially driven biotech platform ...